A Case Series of Malignant Myelomatous Pleural Effusion with Detailed Karyotyping
International Research Journal of Oncology,
Primary myelomatous pleural effusion (PMMPE) is a rare presentation. It is diagnosed based on the presence of plasma cells in pleural fluid along with elevated Monoclonal protein. PMMPE is considered to have poor prognosis with reported survival of 4 to 6 months. This study reports 6 such cases, whose survival was better than earlier reports.
- Multiple myeloma
- pleural effusion
- myelomatous pleural effusion
How to Cite
Mangla A, Agarwal N, Kim GJ, Catchatourian R. Primary malignant myelomatous pleural effusion. Clin Case Rep. 2016;4(8):803-806.
Published 2016 Jul 15.
Babu GK, Saldanha SC, Lokesh KN, et al. Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India. Lung India. 2017;34(2):176-178.
Li-Li Zhang and Yuan-Yuan Li and Cheng-Ping Hu and Hua-Ping Yang. Myelomatous pleural effusion as an initial sign of multiple myeloma—a case report and review of literature, Journal of Thoracic Disease. 2014;6,(7):2014.
Sasser RL, Yam LT, Li CY. Myeloma with involvement of the serous cavities. Cytologic and immunochemical diagnosis and literature review. Acta Cytol. 1990; 34:479-85.3.
Rodriguez JN, Pereira A, Martinez JC, Conde J, Pujol E.Pleural effusion in multiple myeloma. Chest. 1994;105:622-4 Xu XL, Shen YH, Shen Q, et al. A case of bilateral pleural effusion as the first sign of multiple myeloma. Eur J Med Res. 2013;18:7.
Myelomatous Pleural EffusionSharmila Ghosh R, Gopal, SH Advani. J Assoc Physicians India. 2013;54(06):738-739.
Munshi NC, Anderson KC. Plasma cell neoplasms. In: DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Lippincott Williams and Wilkins. 2015; 1682-720.
Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999;341:1565-71.
Rosiñol L, Cibeira MT, Bladé J, Esteve J, Aymerich M, Rozman M, et al. Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica. 2004;89:832-6.
Attili VS, Singh VP, Sundar S, Mehta H, Negi ML, Gogia A, Raju SH, Rai M. Malignant myelomatous pleural effusion with good response to combination chemotherapy. J Assoc Physicians India. 2007;55:595-6.
Rodelo A, Joshi J Myelomatous Pleural Effusion as a Presenting Symptom: A Case Report. Cureus. 2019;11(7):e5153.
Abstract View: 104 times
PDF Download: 44 times